{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:41:03Z","timestamp":1789609263148,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.healun.2014.09.027","type":"journal-article","created":{"date-parts":[[2014,9,28]],"date-time":"2014-09-28T16:15:37Z","timestamp":1411920937000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Outcomes in highly sensitized pediatric heart transplant patients using current management strategies"],"prefix":"10.1016","volume":"34","author":[{"given":"Alfred","family":"Asante-Korang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest K.","family":"Amankwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Lopez-Cepero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ringewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Carapellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Krasnopero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Quintessenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2014.09.027_bib1","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/MOT.0b013e32833de9b2","article-title":"Immunosuppression in the sensitized heart transplant recipient","volume":"15","author":"Eckman","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2014.09.027_bib2","first-page":"II294","article-title":"Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?","volume":"94","author":"Kobashigawa","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2014.09.027_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.athoracsur.2004.03.031","article-title":"Pediatric cardiac transplantation in children with high panel reactive antibody","volume":"78","author":"Jacobs","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2014.09.027_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2007.03.015","article-title":"Survival in allo-sensitized children after listing for cardiac transplantation","volume":"26","author":"Feingold","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2014.09.027_bib5","article-title":"Pediatric heart transplantation in HLA sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population","volume":"116","author":"Pollock-BarZiv","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2014.09.027_bib6","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.healun.2011.06.005","article-title":"Allosensitization and outcomes in pediatric heart transplantation","volume":"30","author":"Mahle","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"suppl 2","key":"10.1016\/j.healun.2014.09.027_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1017\/S1047951111001703","article-title":"Management of children undergoing cardiac transplantation with high panel reactive antibodies","volume":"21","author":"Asante-Korang","year":"2011","journal-title":"Cardiol Young"},{"key":"10.1016\/j.healun.2014.09.027_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"Acute antibody mediated rejection of cardiac transplants","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib9","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1111\/j.1399-0012.2010.01334.x","article-title":"The long term outcome of treated sensitized patients who undergo heart transplantation","volume":"25","author":"Kobashigawa","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0198-8859(01)00380-9","article-title":"B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression","volume":"63","author":"Schuster","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2014.09.027_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/hc1002.105128","article-title":"Intravenous pulse administration of cyclophosphamide is an effective safe treatment for sensitized cardiac allograft recipients","volume":"105","author":"Itescu","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2014.09.027_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.healun.2004.01.006","article-title":"Use of rituximab to decrease panel-reactive antibodies","volume":"24","author":"Balfour","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.healun.2012.05.009","article-title":"HLA desensitization in pediatric heart transplant candidates: efficacy of rituximab and IVIg","volume":"31","author":"Schumaker","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1432-2277.2006.00345.x","article-title":"The emerging role of rituximab in organ transplantation","volume":"19","author":"Becker","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2014.09.027_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/HAB-2004-13301","article-title":"In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody","volume":"13","author":"Sidner","year":"2004","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.healun.2014.09.027_bib16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.healun.2011.08.009","article-title":"Reduction of alloantibodies via proteasome inhibition in cardiac transplantation","volume":"30","author":"Patel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2014.09.027_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2008.12.017","article-title":"Report from a consensus conference on the sensitized patient awaiting heart transplantation","volume":"28","author":"Kobashigawa","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.healun.2004.09.005","article-title":"Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients","volume":"24","author":"Xydas","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2014.09.027_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324981401362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324981401362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:28:54Z","timestamp":1760948934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324981401362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S105324981401362X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2014.09.027","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in highly sensitized pediatric heart transplant patients using current management strategies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2014.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}